Edition:
India

Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

24.33CNY
8:59am IST
Change (% chg)

¥-0.01 (-0.04%)
Prev Close
¥24.34
Open
¥24.33
Day's High
¥24.46
Day's Low
¥24.30
Volume
4,888,070
Avg. Vol
13,817,105
52-wk High
¥29.25
52-wk Low
¥20.95

Select another date:

Fri, Jan 19 2018

Shanghai Pharmaceuticals plans $400 mln share sale to fund production

HONG KONG, Jan 19 Shanghai Pharmaceuticals Holding Co Ltd said on Friday it planned to sell HK$3.13 billion ($400 million) worth of new shares to fund the development of its manufacturing and distribution businesses.

BRIEF-Shanghai Pharmaceuticals Holding To Place 153.2 Mln New H Shares At HK$20.43 Per H Share​

* ‍TO PLACE 153.2 MILLION NEW H SHARES AT HK$20.43 PER H SHARE​

BRIEF-Shanghai Pharmaceuticals Holding units receive GMP certificate

* Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug

BRIEF-Shanghai Pharmaceuticals Holding Announces ‍CSRC's Approval On Issuance Of New Shares

* ANNOUNCES ‍CSRC'S APPROVAL ON ISSUANCE OF NEW 153.2 MILLION H SHARES AT VALUE OF RMB1 PER SHARE​ Source text for Eikon: Further company coverage:

BRIEF-Shanghai Pharmaceuticals Gets Regulatory Approval To Issue Up To 153.2 Mln H-Shares

* SAYS IT GETS SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 153.2 MILLION H-SHARES Source text in Chinese: http://bit.ly/2C81gx7 Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Shanghai Pharmaceuticals Holding To Transfer Entire Stake In Shanghai Huashi Asset Management

* ANNOUNCES ‍TRANSFER OF 100% EQUITY INTEREST IN SHANGHAI HUASHI ASSET MANAGEMENT CO TO A CONTROLLING SHAREHOLDER​

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its Shanghai-based unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

Select another date: